Surgical Science Sweden AB (publ) (STO:SUS)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 1.54B |
| Revenue (ttm) | 992.34M |
| Net Income (ttm) | 66.82M |
| Shares Out | 51.03M |
| EPS (ttm) | 1.31 |
| PE Ratio | 23.05 |
| Forward PE | 13.47 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 280,660 |
| Average Volume | 558,387 |
| Open | 31.18 |
| Previous Close | 31.30 |
| Day's Range | 29.90 - 31.18 |
| 52-Week Range | 23.70 - 162.80 |
| Beta | 0.52 |
| RSI | 52.47 |
| Earnings Date | Feb 19, 2026 |
About STO:SUS
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnosti... [Read more]
Financial Performance
In 2025, STO:SUS's revenue was 992.34 million, an increase of 12.25% compared to the previous year's 884.09 million. Earnings were 66.82 million, a decrease of -49.24%.
Financial StatementsNews
Surgical Science Sweden AB (publ) 2025 Q4 - Results - Earnings Call Presentation
2026-02-20. The following slide deck was published by Surgical Science Sweden AB (publ) in conjunction with their 2025 Q4 earnings call.
Surgical Science Sweden AB (SUSRF) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst ...
Surgical Science Sweden AB (SUSRF) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges
Surgical Science Sweden AB (publ) (SUSRF) Q4 2025 Earnings Call Transcript
Surgical Science Sweden AB (publ) (SUSRF) Q4 2025 Earnings Call Transcript
Q4 2025 Surgical Science Sweden AB Earnings Call Transcript
Q4 2025 Surgical Science Sweden AB Earnings Call Transcript
Surgical Science Sweden AB (publ) (SUSRF) Analyst/Investor Day Transcript
Surgical Science Sweden AB (publ) (SUSRF) Analyst/Investor Day Transcript
Surgical Science Sweden AB (publ) (SUSRF) Q3 2025 Earnings Call Transcript
Surgical Science Sweden AB (publ) (OTCPK:SUSRF) Q3 2025 Earnings Call November 13, 2025 5:00 AM EST Company Participants Tom Englund - Chief Executive Officer Anna Ahlberg - Chief Financial Officer Co...